Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...
China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...
Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...
Eli Lilly and Company (Lilly Gulf) has announced the launch of Nujoom Al Ghad, a new graduate programme designed to deve...
Australia-based CSL and Swiss firm Alentis Therapeutics have entered into an exclusive global collaboration agreement to...
Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Bui...
Fatty liver disease is commonly associated with obesity, yet a growing number of people with normal body weight develop ...
Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-an...
China-based Hengrui Pharma has entered into a license agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon...
The Ministry of Health and Welfare, South Korea government, has announced that it will open K-Beauty experience and reta...
Japan’s Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPY...
Australia-based Telix Pharmaceuticals has announced that the United States (US) Food and Drug Administration (FDA) has g...
Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthc...
Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisati...
Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials ...
Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...
InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, ha...
United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...
Aptar Pharma, a global leader in drug delivery, dosing and protection technologies and services, has announced a new res...
Neurology, once considered the graveyard of pharma development, is entering a new era. After years of high clinical fail...
On March 13, 2026, China’s National Medical Products Administration (NMPA) granted Class III registration to NEO, ...
Amyloid-targeting therapies have arrived across Asia-Pacific faster than the infrastructure needed to decide who should ...
The success of mRNA vaccines during the COVID-19 pandemic transformed the technology from a promising scientific approac...
How do you view the multiple myeloma market in APAC, addressing its affordability and accessibility? Asia Pacific is at...
Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, has reached agre...
